Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
0.923
-0.014 (-1.54%)
At close: May 16, 2022 4:00 PM
0.910
-0.013 (-1.408%)
After-hours:May 16, 2022 7:59 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Year | 2020 | 2019 | 2018 |
|---|---|---|---|
| Selling, General & Admin | 3.64 | 3.35 | 1.31 |
| Research & Development | 1.31 | 1.07 | 3.7 |
| Operating Expenses | 4.95 | 4.42 | 5.01 |
| Operating Income | -4.95 | -4.42 | -5.01 |
| Interest Expense / Income | 0.16 | 0 | 0 |
| Other Expense / Income | -0.06 | -0.01 | -0.15 |
| Pretax Income | -5.05 | -4.41 | -4.86 |
| Net Income | -5.05 | -4.41 | -4.86 |
| Net Income Common | -5.05 | -4.41 | -4.86 |
| Shares Outstanding (Basic) | 73 | 71 | 59 |
| Shares Outstanding (Diluted) | 73 | 71 | 59 |
| Shares Change | 1.96% | 21.09% | - |
| EPS (Basic) | -0.07 | -0.06 | -0.08 |
| EPS (Diluted) | -0.07 | -0.06 | -0.08 |
| Free Cash Flow Per Share | -0.04 | -0.03 | -0.02 |
| EBITDA | -4.89 | -4.41 | -4.86 |
| EBIT | -4.89 | -4.41 | -4.86 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).